-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PYOJg0XtyhVwaKeI3z7CYMzwHkwQhpQCy6NXE316Tv4VulzouPZP6aJNuZhVj6fG p78q6rNV7LaKq9pK1TiZnA== 0001408617-08-000022.txt : 20080319 0001408617-08-000022.hdr.sgml : 20080319 20080319160042 ACCESSION NUMBER: 0001408617-08-000022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080317 FILED AS OF DATE: 20080319 DATE AS OF CHANGE: 20080319 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nader Francois CENTRAL INDEX KEY: 0001365343 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 08699396 BUSINESS ADDRESS: BUSINESS PHONE: 801-583-4939 MAIL ADDRESS: STREET 1: 383 COLOROW DRIVE CITY: SALT LAKE CITY STATE: X1 ZIP: 84108 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2008-03-17 0000890465 NPS PHARMACEUTICALS INC NPSP 0001365343 Nader Francois 550 HILLS DRIVE BEDMINSTER NJ 07921 0 1 0 0 SVP & COO Common Stock 2008-03-17 4 A 0 50000 0 A 69350 D Stock Option 3.85 2008-03-17 4 A 0 100000 0 A 2018-03-17 Common Stock 100000 100000 D Represents restricted stock units (contingent rights to receive shares of NPS common stock), which vest in three equal installments beginning on the first anniversary of date of grant. Stock options granted under the 1998 Stock Option Plan. The options become exercisable based on the following four-year vesting schedule: 28% on the first anniversary of the grant, and 2% each month thereafter. Andrew Rackear 2008-03-19 -----END PRIVACY-ENHANCED MESSAGE-----